Novavax Inc (NASDAQ:NVAX)

11.62
Delayed Data
As of Jul 27
 -0.17 / -1.44%
Today’s Change
3.92
Today|||52-Week Range
13.12
+95.95%
Year-to-Date

Today’s Trading

Previous close11.79
Today’s open11.75
Day’s range11.08 - 11.75
Volume4,399,867
Average volume (3 months)3,649,297
Market cap$3.2B
Dividend yield--
Data as of 3:59pm ET, 07/27/2015

Growth & Valuation

Earnings growth (last year)-19.35%
Earnings growth (this year)-9.99%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+46.59%
P/E ratioNM
Price/Sales43.68
Price/Book12.26

Competitors

 Today’s
change
Today’s
% change
RDUSRadius Health Inc-1.35-1.80%
KITEKite Pharma Inc+0.14+0.20%
HALOHalozyme Therapeutic...-0.44-1.89%
CTLTCatalent Inc+1.52+5.05%
Data as of 4:01pm ET, 07/27/2015

Financials

Next reporting dateAugust 7, 2015
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$30.7M
Annual profit (last year)-$82.9M
Net profit margin-270.55%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Chief Financial Officer, Treasurer &
Senior VP
Barclay A. Phillips
Corporate headquarters
Gaithersburg, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers